Structure and function of the epidermal barrier in patients with atopic dermatitis - treatment options. Part one

被引：11
作者：
Pelc, Jagoda [1 ]
Czarnecka-Operacz, Magdalena [1 ]
Adamski, Zygmunt [1 ]
机构：
[1] Poznan Univ Med Sci, Dept Dermatol & Venereol, 49 Przybyszewskiego St, PL-60355 Poznan, Poland
来源：
POSTEPY DERMATOLOGII I ALERGOLOGII | 2018年 / 35卷 / 01期
关键词：
atopic dermatitis; epidermal barrier; filaggrin; cytokines; IMMUNE DYSREGULATION; SKIN BARRIER; FILAGGRIN; DISEASE;
D O I：
10.5114/ada.2018.73159
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Atopic dermatitis is a chronic, recurrent inflammatory skin disease, which is frequently familial. The main cause of the disease seems to be a defect of the epidermal barrier resulting from a genetic predisposition concerning the epidermis, functioning of the immune system as well as environmental factors (which are not related to the immune system). Genes responsible for encoding protein S100, filaggrin, proteases and their inhibitors are the main genes related to the problem of epidermal barrier dysfunction. There is a close connection between structural and immunological processes. Increased expression of cytokine Th2 profile belongs to the latter category. The objective of the present paper is to describe the influence of aforementioned factors on epidermis structure and dysfunction which leads to clinical symptoms of atopic dermatitis.
引用
收藏
页码：1 / 5
页数：5
相关论文
共 15 条
  • [1] Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report
    Akdis, C. A.
    Akdis, M.
    Bieber, T.
    Bindslev-Jensen, C.
    Boguniewicz, M.
    Eigenmann, P.
    Hamid, Q.
    Kapp, A.
    Leung, D. Y. M.
    Lipozencic, J.
    Luger, T. A.
    Muraro, A.
    Novak, N.
    Platts-Mills, T. A. E.
    Rosenwasser, L.
    Scheynius, A.
    Simons, F. E. R.
    Spergel, J.
    Turjanmaa, K.
    Wahn, U.
    Weidinger, S.
    Werfel, T.
    Zuberbier, T.
    [J]. ALLERGY, 2006, 61 (08) : 969 - 987
  • [2] Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
    Boguniewicz, Mark
    Leung, Donald Y. M.
    [J]. IMMUNOLOGICAL REVIEWS, 2011, 242 : 233 - 246
  • [3] Epidermal Barrier Dysfunction in Atopic Dermatitis
    Cork, Michael J.
    Danby, Simon G.
    Vasilopoulos, Yiannis
    Hadgraft, Jonathan
    Lane, Majella E.
    Moustafa, Manar
    Guy, Richard H.
    MacGowan, Alice L.
    Tazi-Ahnini, Rachid
    Ward, Simon J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (08) : 1892 - 1908
  • [4] The frequency of polymorphic variants of filaggrin gene and clinical atopic dermatitis
    Filipowska-Gronska, Agata
    Werynska-Kalemba, Maria
    Bozek, Andrzej
    Filipowska, Barbara
    Zebracka-Gala, Jadwiga
    Rusinek, Dagmara
    Kula, Dorota
    Jarzab, Jerzy
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2016, 33 (01): : 37 - 41
  • [5] Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis
    Furue, M.
    Yamamura, K.
    Kido-Nakahara, M.
    Nakahara, T.
    Fukui, Y.
    [J]. ALLERGY, 2018, 73 (01) : 29 - 36
  • [6] Kurowski M, 2009, ALERG ASTMA IMMUNOL, V14, P95
  • [7] New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation
    Leung, Donald Y. M.
    [J]. ALLERGOLOGY INTERNATIONAL, 2013, 62 (02) : 151 - 161
  • [8] Pathogenesis of atopic dermatitis
    Leung, DYM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (03) : S99 - S108
  • [9] The multifunctional role of filaggrin in allergic skin disease
    McAleer, Maeve A.
    Irvine, Alan D.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : 280 - 291
  • [10] Pathogenesis of atopic dermatitis
    Peng, W.
    Novak, N.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (03) : 566 - 574
12